Innovation in Cognitive Pathology - Interview of Dr. Sibille at the annual meeting of the American Psychiatry Association
***Extracted from HCP Live*** Etienne Sibille, PhD: Innovations in Cognitive…
New Review in Trends in Pharmacological Sciences - GABAA receptors as targets for treating affective and cognitive symptoms of depression
A neuroactive steroid (NAS) targeting δ-GABAA receptors has been approved for…
Krembil Foundation Grant awarded to Drs. Sibille and Tomoda
“Targeting Reduced BDNF/TrkB-Mediated Neuroplasticity in Brain Disorders” PI:…
We Are Hiring - PostDoc with Cell Culture Experience
Position Summary: Reduced brain cell structure and function contribute to…
A new grant for studying the role of elevated MAOA in depression and its treatment.
Congratulations to Dr Sibille and collaborators (Drs Meyer, Banasr, Tomoda,…
New Research Article - Reduced inhibition in depression impairs stimulus processing in human cortical microcircuits
Through a multicentered collaboration, joining experts from the Centre for…
Living With Dementia - Dr. Sibille presents how his work can help (CTV Your Morning)
LIVING WITH DEMENTIA - CTV Your Morning Link…
What could prevent suicide? - Read the piece about CAMH research from TORONTO STAR
What could prevent suicide? For CAMH and mental health advocates, it’s advances…
New Review - From serendipity to rational drug design in brain disorders: in silico, in vitro, and in vivo approaches
In this review, the authors provides an overview on the current state of drug…
What Happens to Our Brains When We Get Depressed?
The human brain, in all its complexity, is nearly impossible to model.…